[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neural Therapeutics Inc. (NURL.CN)

Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neural Therapeutics Inc. 1-130 Adelaide Street West Suite 3002 Toronto ON M5H 3P5 CAN

https://www.neuraltherapeutics.ca

Sector:

N/A

Description:

Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.

Key Statistics

Overview:

Market Capitalization, $K 2,538
Shares Outstanding, K 169,201

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -1,026 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -391 K

Growth:

1-Year Return -50.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 03/25/26
Next Earnings Date N/A
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year 33.80%
Dividend Payout Ratio 0.00%

NURL.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,179.18%
Return-on-Assets % -114.98%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 3.89
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.